Introduction {#S1}
============

Oxidative stress with increased production of reactive oxygen species (ROS) has been implicated in a wide variety of pathological conditions, such as inflammation, atherosclerosis, ischemia-reperfusion injury, hypercholesterolemia, hypertension, diabetes, and heart failure ([@B125]; [@B116]; [@B74]; [@B185]; [@B61]; [@B112]; [@B88]; [@B62]; [@B232]). Growing evidence indicates that overproduction of ROS can lead to endothelial barrier dysfunction with subsequent increased vascular permeability, tissue damage, and organ dysfunction ([@B47]; [@B28]; [@B81]; [@B238]; [@B80]; [@B233], [@B234], [@B232]). However, the precise role played by each ROS and their products in normal and pathological processes is very complex, and the mechanisms of ROS-induced increased vascular permeability under inflammation and disease conditions remain largely unknown. This review will discuss the sources of ROS and antioxidants in the vasculature with focus on the effects and mechanisms of different ROS and ROS-derived reactive nitrogen species (RNS) on endothelial barrier function. The advantages and limitations of different experimental approaches used for the study of ROS-induced endothelial barrier function will also be discussed in this review.

Sources of ROS, Redox-Crosstalk, and Antioxidants in Vascular System {#S2}
====================================================================

Reactive oxygen species are a collective term that refers to both oxygen-derived unstable free radicals, such as superoxide anion, hydroxyl radical, oxygen radical, NO, and non-free radicals, such as hydrogen peroxide (H~2~O~2~), hypochlorus acid, peroxynitrite (ONOO^--^), and ozone ([@B28]; [@B119]; [@B61]; [@B62]). ROS are ubiquitous and formed continuously in small amounts during the normal metabolism of cells and are normally inactivated by endogenous antioxidant defense mechanisms ([@B115]; [@B241]). The sources of different ROS and antioxidant enzymes in vascular diseases have been extensively reviewed by several authors ([@B28]; [@B119]; [@B138]; [@B61]; [@B136]; [@B88]; [@B62]). The major sources of ROS in ECs are from NADPH oxidase (Nox), xanthine oxidase (XO), mitochondria, and dysfunctional eNOS. Other potential vascular sources of ROS include cytochrome p450 mono-oxygenase, cyclo-oxygenase and lipoxygenase, NOS, and peroxidases ([@B61]). In addition to the ROS derived from activated ECs, the vascular endothelium is constantly exposed to various blood-borne agents and is the primary target for oxidants released from activated blood cells during inflammation. The activated neutrophils could release large amount of ROS to the circulation via membrane-bound NADPH oxidase during neutrophil respiratory burst, which provide the killing power for invading pathogens, but also cause host tissue injury and endothelial barrier dysfunction ([@B30]; [@B9]; [@B40]; [@B99]; [@B119]; [@B79]; [@B238]; [@B61]). Importantly, there appears to be significant redox crosstalk between these pro-oxidant systems where ROS produced by one enzyme system can enhance the activity of other ROS-producing systems, leading to feed-forward processes with augmented ROS production and oxidative stress ([@B27]; [@B61]; [@B41]; [@B239]; [@B42]; [@B232]). For instance, NADPH oxidase-derived ROS have been implicated in the activation of XO ([@B124]; [@B108]), mitochondrial ROS production ([@B213]; [@B96]), uncoupling of eNOS ([@B107]), and NO/O~2~^--^ derived ONOO^--^ formation ([@B160]; [@B219]; [@B164]; [@B149]; [@B192]; [@B232]).

Reactive oxygen species in the cells and tissues are kept in balance by the anti-oxidant enzymes that regulate and often reduce the level of ROS in biological system. Vascular cells are equipped with several of these protective enzymes such as superoxide dismutase (SOD), catalase, glutathione peroxidase, thioredoxin, heme oxygenase, and paraoxonase ([@B61]). Several non-enzymatic antioxidants are also found in the biological systems such as endogenous glutathione, uric acid and bilirubin, and ingested antioxidant vitamins ([@B61]). While ROS at moderate and low concentrations have important signaling roles and beneficial effects under physiological conditions ([@B190]; [@B60]; [@B89]; [@B163]; [@B196]; [@B53]; [@B203]), at higher concentrations, especially with reduced antioxidant counter balance, ROS generate oxidative stress under pathophysiologic conditions causing potential damage to the biomolecules, disruption of cellular function and promoting disease progression ([@B223]; [@B183]; [@B115]; [@B119]; [@B149]; [@B192]; [@B61]; [@B113]). Although ample experimental evidence support the role of certain antioxidant enzymes or non-enzymatic antioxidants in ameliorating oxidative stress-mediated vascular damages, clinical studies so far have not been able to demonstrate conclusive results ([@B119]; [@B108]; [@B61]; [@B24]). These led more studies to focus on the transcriptional regulations of antioxidant genes. Among varieties of redox-sensitive transcription factors, nuclear factor (erythroid 2--related) factor 2 (Nrf2) has recently been drawn attention and referred to as master antioxidant that regulates a wide variety of genes encoding detoxification enzymes and antioxidant proteins ([@B118]; [@B34]; [@B2]). Recent development of the role of Nrf2 in the regulation of redox homeostasis and its therapeutic prospects are further discussed in the later section.

Leukocyte-Dependent ROS-Mediated Microvascular Barrier Dysfunction {#S3}
==================================================================

Acute inflammation is characterized by increased microvascular permeability to plasma proteins and leukocyte recruitment into inflammatory sites, which occurs mainly at post-capillary venules. The recruited granulocytes upon activation release various substances including ROS during respiratory bust. Due to its large quantity over other sources, ROS have been demonstrated to play a major role in the acute activation of endothelial cells, resulting in vascular leakages ([@B47]; [@B236]; [@B238]; [@B69]). The leukocyte-dependent ROS-mediated microvascular barrier dysfunction was supported by experimental evidence that the blocking antibodies, induction of neutropenia, or the application of superoxide scavenger SOD reduced vascular damages in reperfusion of ischemic tissues and other inflammatory conditions ([@B95]; [@B30]; [@B87]; [@B69]).

Role of Leukocyte Adhesion/Emigration in Microvessel Permeability {#S3.SS1}
-----------------------------------------------------------------

Leukocyte adhesion, as a necessary step leading to granulocytes migration from the vascular lumen to the interstitial space, has been indicated as a prerequisite for leukocyte to induce endothelial injury in studies conducted in autologous blood perfused organ or tissues ([@B30]; [@B99]). Supporting this notion, some *in vitro* studies reported that the adhesion process could directly trigger intracellular signals in ECs or protease release from neutrophils ([@B133]) resulting in increased EC permeability ([@B48]). However, when vascular permeability and leucocyte/endothelium interactions were evaluated simultaneously in vasculature, the sites of the leucocyte adhesion and emigration were not always associated with vascular leakages ([@B83]; [@B121]; [@B11]; [@B227]). Multiple studies revealed temporal and spatial dissociations of leucocyte adhesion and/or emigration from vascular leakages, indicating that mechanisms other than the adhesion process could be critical to the vascular barrier dysfunction during inflammation ([@B73]; [@B87]; [@B227]; [@B77]).

Role of Neutrophil Released ROS in Microvessel Permeability {#S3.SS2}
-----------------------------------------------------------

Whether leucocyte/endothelium interactions would be the cause of increased microvessel permeability has been controversial for decades ([@B30]; [@B100]; [@B13]; [@B133]; [@B227]; [@B77]). On one hand, studies reported leucocyte adhesion and emigration to be the critical event leading to tissue and organ dysfunction during inflammation, and the number of adherent leucocytes was considered as an index for the severity of tissue injury and vascular dysfunction ([@B193]; [@B84]). On the other hand, experimental evidence showed that the albumin leakage sites were often distinct from those of leucocyte adhesion and emigration, indicating independent mechanisms to be involved in the induction of leucocyte adhesion and increased microvessel permeability ([@B83]; [@B187]; [@B12]; [@B227]). Studies conducted in intact microvessels by dissecting the processes clarified some of the debating issues derived from different experimental approaches. The experiments shown in [Figure 1](#F1){ref-type="fig"} demonstrated that the systemic application of TNF-α causes a significant number of leucocyte adhesion at vascular walls, but no increased microvessel permeability was observed ([@B227]). However, increased permeability occurred after fMLP was applied to TNF-α-induced adherent leukocytes and the application of SOD blocked such increased permeability, demonstrating ROS-mediated permeability increases. Importantly, in the presence of fMLP, the magnitude of the permeability increases was directly correlated with the number of adherent of leukocytes, indicating that larger quantity of released ROS produced by higher number of adherent leukocytes results in higher magnitude of permeability increases ([@B238]). [Figure 1D](#F1){ref-type="fig"} basically shows ROS dose-dependent permeability increases in intact microvessels. These observations suggest that in the presence of activating stimuli for leukocyte respiratory burst, the number of adherent leukocytes could predict the severity of vascular dysfunction as others concluded ([@B193]; [@B84]).

![TNF-α-induced adherent leukocytes do not increase microvessel permeability until exposure to fMLP. **(A)** Lp measurements in an individually perfused rat mesenteric venule. The time course of the measured Lp shows that neither TNF-α-induced leukocyte adhesion alone nor stationary flow in the presence of adherent leukocytes (to allow accumulation of locally released agents) changed Lp. Transient increase in Lp only occurred after adherent leukocytes were exposed to fMLP (10 μmol/L). **(B)** Summary results showing relationship between number of adherent leukocytes (bottom graph) and changes in microvessel Lp (top graph). Significant increases in Lp only occurred after fMLP was applied to perfusate or superfusate, and was attenuated or prevented by pretreatment of the vessel with an iron chelator DFO or SOD, indicating the role of released ROS in increased Lp. **(C)** Images of individually perfused venules under control conditions and after TNF-α-induced leukocyte adhesion (2 h after systemically applied TNF-α). **(D)** The positive correlation between the increased Lp and the number of adherent leukocytes with fMLP stimulation (•) indicates that the quantity of fMLP-induced release of ROS correlated with the number of adherent leukocytes determines the magnitude of Lp increases. Modified and used with permission ([@B238]).](fphys-11-00472-g001){#F1}

Although neutrophil/endothelium interactions is an essential part of acute inflammatory responses, a significant portion of responsive leucocytes remains in the peripheral circulation during inflammation. It is well known that isolated neutrophils could release large quantities of ROS through respiratory burst in response to a variety of stimuli, which are detectable by chemiluminescence measurement ([@B38]; [@B9]). In addition to ROS-mediated permeability increased through adherent leukocyte release of ROS, studies showed that fMLP- or C5a-activated non-adherent neutrophils (suspension in the perfusate) could also increase permeability in isolated coronary venules ([@B198]) and intact mesenteric venules ([@B236]). These experimental evidence strongly support that ROS released from activated leukocytes, in either circulating or adherent form, constitute the major source of ROS in the plasma during inflammation and disease conditions, which could directly activate ECs lining the vascular walls (details discussed below), contributing to leukocyte-dependent increases in vascular permeability. These results also suggested that the physical interaction between leukocytes and endothelium through adhesion/emigration was not the direct cause of vascular leakages, and the adhesion process was also not the direct trigger for neutrophils to release ROS.

Neutrophil Priming and ROS Generation {#S3.SS3}
-------------------------------------

Many cytokines and pro-inflammatory mediators have been reported as neutrophil primers that do not present the effector function on their own, but enable neutrophils to have enhanced responses to additional activating stimuli ([@B37]; [@B207]; [@B238]; [@B56]; [@B130]). As shown in [Figure 2](#F2){ref-type="fig"}, pre-exposure of neutrophils to a common priming cytokine, TNF-α, through systemic application *in vivo* did not induce ROS release as measured by chemiluminescence activity, but markedly augmented superoxide production in response to other mediators, such as fMLP ([@B238]). The application of anti-TNF MoAb blocked TNF-α-mediated neutrophil priming ([@B207]). Under *in vivo* pathological conditions, systemically elevated cytokine levels or other priming agents such as chemoattractants, or microbial products could transform neutrophils into a primed state resulting in potentiated ROS release in responses to additional stimuli ([@B38]; [@B56]; [@B130]). Neutrophil priming with increased quantity of released ROS plays an important role in host defense against microbial pathogens, but also increases the risk for extensive tissue damage and endothelial barrier dysfunction. Severe clinical conditions such as adult respiratory distress syndrome ([@B151]), organ failure, and mortality ([@B153]) are often associated with high plasma levels of inflammatory cytokines and/or endotoxin, and those stimuli-primed neutrophils with enhanced respiratory burst may explain the exacerbated tissue damages commonly observed in those conditions. Recent studies also suggest that primed neutrophils, in addition to enhanced oxidative burst, also involve activations of other neutrophil activities such as adhesion, surface receptor expression, etc ([@B130]). Neutrophil priming and de-priming as well as the levels of the priming are complex processes which vary depending on the concentration of priming agents, exposure time, and the type of priming agents ([@B157]; [@B123]). The major priming agents, underlying mechanisms, and signaling pathways involved in priming neutrophil respiratory burst have been reviewed elsewhere in detail ([@B38]; [@B56]; [@B130]). In contrast to the priming agents that enhance the neutrophil responsiveness to stimuli, there are also cytokines that suppress neutrophil bacterial killing power with reduced ROS release. Multiple studies demonstrated that resistin, a cytokine commonly increased in chronic kidney diseases or sepsis, selectively inhibits neutrophil oxidative burst in response to stimuli and impair its bacterial killing capacity, resulting in immunosuppression ([@B36]; [@B23]; [@B129]). A better understanding of the neutrophil priming *in vivo* under disease conditions may benefit the development of therapeutic strategies to minimize vascular damage, while enhancing its oxidative killing power at the bacterial battle field.

![Priming effect of TNF-α on fMLP-stimulated neutrophil respiratory burst measured by chemiluminescence (CL). Preexposure of neutrophils to TNF-α through systemic application *in vivo* did not change basal CL but potentiated fMLP-stimulated CL by 3.1-fold. Bar graph shows magnitude difference in fMLP-stimulated CL between unprimed and TNF-α-primed neutrophils through *in vivo* application. Inset: representative individual time course from each group of experiments. Used with permission ([@B238]). \*Significant difference from fMLP stimulation alone.](fphys-11-00472-g002){#F2}

Leukocyte-Derived Myeloperoxidase and Hypohalous Acids in Endothelial Dysfunction and Cardiovascular Diseases {#S4}
=============================================================================================================

Neutrophils in response to stimuli not only release ROS but also release myeloperoxidase (MPO), an enzyme closely linked to both inflammation and oxidative stress ([@B3]; [@B141]). MPO is a member of the heme peroxidase-cyclooxygenase super family ([@B93]; [@B46]; [@B205]; [@B45]). It is released by activated neutrophils, monocytes, and some tissue macrophages into extracellular spaces, where it catalyzes the conversion of hydrogen peroxide to hypohalous acids in the presence of halide and pseudo-halide ions ([@B204]; [@B72]). This enzyme is abundantly expressed in granulocytes and accounts for approximately 5% of a neutrophil's dry weight ([@B171]; [@B45]). The major reactive species produced by MPO under physiological conditions are hypochlorous acid and hypothiocyanous acid. While hypohalous acids have potent antibacterial, antiviral, and antifungal properties and play key roles in the human immune system ([@B72]; [@B15]), an excessive recruitment and activation of leukocytes in the affected organ(s) under inflammatory conditions can amplify the inflammatory response and contribute to organ injury and dysfunction ([@B228]; [@B188]; [@B93]; [@B109]; [@B46]; [@B15]). MPO-derived oxidants have been shown to damage vascular ECs, basement membrane and matrix components, and lead to leakage of plasma proteins, microvascular hemorrhage, and atherogenesis ([@B117]; [@B221]; [@B144]; [@B215]; [@B199]; [@B224]). MPO and its oxidant end products have been found in both human and experimental atherosclerotic lesions ([@B44]; [@B208]; [@B105]), and MPO-induced nitrotyrosine (NO~2~Tyr) formation in the vessel wall affects the matrix protein structure and function ([@B109]). Some studies reported that MPO directly modulates endothelial NO production, NO bioavailability, and endothelium-dependent vasodilatation during acute inflammation ([@B228]; [@B55]; [@B109]). MPO-derived oxidants have also been found to inhibit sarco/endoplasmic reticulum Ca^2+^-ATPase activity, perturb Ca^2+^ homeostasis, resulting in the accumulation of cytosolic Ca^2+^ ([@B39]), caspase-3 activation and apoptosis of ECs in culture ([@B188]). The direct effect of hypochlorous acid (HOCL) on endothelial permeability has been evaluated in cultured bovine pulmonary artery EC monolayers ([@B195]; [@B146]). Results showed that HOCl, either given directly or produced by conversion of H~2~O~2~ with MPO and Cl^--^, caused immediate changes in EC shape (cell retraction), electrical resistance, and increases in protein permeability (^125^I-labeled albumin clearance). The HOCl-mediated responses were shown to be faster and greater than those induced by H~2~O~2~ ([@B146]). The HOCl (10 to 100 μM)-induced increases in EC monolayer permeability occurred within 1--3 min, whereas H~2~O~2~-induced permeability increases in the same type of cultured ECs required higher concentration (50 to 400 μM) and longer exposure time (over 30 min), indicating that HOCI is a more potent oxidant than H~2~O~2~ to disrupt endothelial barrier function ([@B146]). Additionally, the MPO and MPO-catalyzed HOCI amplified high glucose-induced endothelial dysfunction in cell culture and rat aorta ([@B197]). Excessive production of hypohalous acids has been shown to be directly linked to many cardiovascular diseases ([@B229]; [@B3]; [@B141]) and circulating levels of MPO is clinically used as a biomarker to predict the health outcomes in those patients ([@B10]; [@B25]; [@B128]; [@B131]; [@B170]). However, despite the growing evidence and interest in MPO-derived oxidant-induced cellular and molecular damage, the role of different MPO-derived species and mechanisms responsible for increased cardiovascular disease risk and patient outcomes are poorly defined and need further elucidation in detail ([@B45]; [@B15]; [@B141]).

ROS-Mediated Microvessel Barrier Dysfunction {#S5}
============================================

Reactive oxygen species are derived from molecular oxygen by sequential monovalent reductions and the essential step in this process is the univalent enzymatic reduction of oxygen to superoxide radical ([@B47]; [@B52]; [@B9]; [@B61]). Superoxide in the extracellular space can spontaneously dismutate into H~2~O~2~ and O~2~, and the simultaneous presence of superoxide, H~2~O~2~, and chelated metal catalysts in the extracellular space can result in the generation of more active hydroxyl radical. Superoxide is unstable with a lifetime of few milliseconds at neutral pH, and hydroxyl is extremely reactive and short-lived free radical produced in biological systems ([@B241]; [@B136]).

Among ROS, H~2~O~2~ is particularly important in microvascular injury because it is relatively stable and has longer half-life than superoxide, and it is easily diffusible within and between cells ([@B136]). In light of the sources of *in vivo* oxidative stress, *in vitro* oxidative stress can be produced by direct application of oxidants such as H~2~O~2~ or continuous generation of superoxide or H~2~O~2~ in enzymatic systems ([@B52]). One of the most widely used models of oxidative stress is the hypoxanthine (HX)/XO enzyme system (HX/XO) where XO acting aerobically on HX produces superoxide and H~2~O~2~ ([@B47]; [@B52]). While there is no clear evidence for the effects of blockade of production or bioactivity of endogenous oxidants on basal microvascular permeability ([@B104]), the reduction of endogenous NO has been shown to cause an immediate increase in ICAM-1-mediated leukocyte adhesion ([@B220]; [@B66]). Both *in vitro* and *in vivo* studies demonstrated that exogenous administration of H~2~O~2~ or HX/XO system can directly cause oxidative stress and increase the permeability of endothelial monolayers ([@B175]; [@B179]; [@B19]; [@B51]; [@B147]), individually perfused intact microvessels ([@B238]; [@B233], [@B234]), whole vascular beds ([@B47]; [@B150]), and the isolated organs ([@B86]; [@B14]; [@B172]). The protective effect of antioxidants (such as superoxide dismutase, catalase, XO inhibitor) against the permeability increases in different experimental models ([@B47]; [@B150]; [@B175]; [@B92]; [@B147]; [@B233]) and clinical study ([@B21]) further implicated the role of oxidative stress in endothelial barrier dysfunction. Importantly, some studies in cultured ECs and intact microvessels have demonstrated that superoxide and H~2~O~2~ exert different effects on the endothelial permeability ([@B19]; [@B125]; [@B147]; [@B233]) with different cellular mechanisms ([@B126]; [@B147]; [@B234]). Details are discussed below.

Differential Effects of Superoxide and H~2~O~2~ on EC \[Ca^2+^\]~i~ and Microvessel Permeability {#S5.SS1}
------------------------------------------------------------------------------------------------

A number of *in vitro* studies in cultured monolayers of ECs from different origin have demonstrated that H~2~O~2~ can disrupt endothelial barrier function in a concentration-dependent manner with variable magnitudes ([@B175]; [@B179], [@B180]; [@B19]; [@B51]), and oxidant-mediated endothelial barrier dysfunction could be partially reversed and can occur in the absence of cytotoxicity ([@B175]; [@B126]; [@B71]). H~2~O~2~-induced permeability increases in cultured ECs (measured by different methods) were reported to be rapid ([@B126]; [@B80]) or delayed ([@B19]; [@B147]). Similarly, both early and delayed permeability increases were also reported for superoxide generated by HX-XO in cultured EC monolayers ([@B19]; [@B147]). The results of these *in vitro* studies were quite different and could be related to different species or culture conditions of the ECs or to the method differences in permeability measurements.

In intact microvessel studies the inflammatory mediator-induced increases in microvessel permeability are mediated by transiently increased EC \[Ca^2+^\]~i~ ([@B8]; [@B237]; [@B235]). ROS has also been shown to induce increases in EC \[Ca^2+^\]~i~ by many *in vitro* and *in vivo* studies with exogenously applied ROS as stimuli ([@B51]; [@B210]; [@B80]) which correlates with increased endothelial permeability ([@B175]; [@B180]; [@B238]; [@B233], [@B234]). Superoxide, H~2~O~2~, and hydroxyl radical have been shown to exert differential effects on \[Ca^2+^\]~i~ in human ECs ([@B52]). Importantly, it is reported that the toxicity of high levels of ROS could lead to a massive, steady influx of extracellular Ca^2+^, whereas low concentrations of ROS induce only transient Ca^2+^ changes, thus acting as signaling agonists ([@B210]). Certain *in vitro* studies reported rapid and transient increases in EC \[Ca^2+^\]~i~ when ECs were exposed to H~2~O~2~ ([@B180]; [@B210]), similar to those found with applied superoxide derived by HX/XO, while others reported delayed increases in EC \[Ca^2+^\]~i~ with H~2~O~2~ exposure ([@B52]; [@B126]; [@B147]).

When the changes in microvessel permeability and endothelial \[Ca^2+^\]~i~ were assessed under identical experimental conditions in individually perfused intact microvessels, H~2~O~2~ and superoxide demonstrated different effects on EC \[Ca^2+^\]~i~ and microvessel permeability ([@B233]). [Figures 3A,B](#F3){ref-type="fig"} shows that superoxide, a potent reactive oxygen species (generated by HX/XO), induces immediate and transient increases in EC \[Ca^2+^\]~i~ and microvessel permeability (measured by hydraulic conductivity, Lp) similar to inflammatory mediator-induced responses ([@B233]). Whereas H~2~O~2~, a relatively stable reactive oxygen metabolite at a pathologically relevant concentration of 10 μM, induces delayed and progressive increases in EC \[Ca^2+^\]~i~ and Lp in a time and concentration dependent manner ([Figures 3C,D](#F3){ref-type="fig"}; [@B233], [@B234], [@B232]). Importantly, the increased EC \[Ca^2+^\]~i~ in either HX/XO or H~2~O~2~ perfused vessels were well correlated with the time course of the increases in microvessel Lp. Inhibiting Ca^2+^ influx by LaCl~3~ prevented the permeability increase induced by HX/XO or H~2~O~2~, thus indicating that Ca^2+^ influx plays an essential role in both superoxide- and H~2~O~2~-induced permeability increases. These findings also indicate that long-term exposure of H~2~O~2~ at a low concentration may cause accumulative lipid oxidation and membrane damage, resulting in Ca^2+^ overload and prolonged irreversible permeability increases ([@B234], [@B232]). Detailed mechanisms are discussed below. These reported long lasting effects of H~2~O~2~ could play a key role in ROS-mediated vascular dysfunction, which may resemble the pathogenesis of diabetes and other disease associated microvascular dysfunction.

![Results of individually perfused rat mesenteric venules demonstrating differential actions of superoxide and H~2~O~2~ on endothelial cell \[Ca^2+^\]~i~ and microvessel permeability (measured by hydraulic conductivity, Lp). **(A,B)** Individual experiments showing transient increases in Lp and EC \[Ca^2+^\]~i~ after exposure to superoxide generated by HX/XO. **(C,D)** In contrast to the immediate and transient effects of superoxide, H~2~O~2~ induced delayed and progressive increases in EC \[Ca^2+^\]~i~ and Lp demonstrating a dose and time-dependent manner. Modified and used with permission ([@B233], [@B234]).](fphys-11-00472-g003){#F3}

Methodology Differences in Exogenously Applied ROS {#S5.SS2}
--------------------------------------------------

In most of the *in vitro* studies, the applied H~2~O~2~ or HX/XO to generate superoxide was often given to cultured cells as bolus, which causes an immediate reaction of the reactive agents with the cells and other components in the medium and lost the reactive activities quickly. Under those conditions, hundreds of μM or even mM concentrations of peroxide (far more than the pathological concentrations detected in the plasma) were usually needed to see the responses ([@B1]; [@B110]; [@B85]; [@B189]). Under *in vivo* conditions, the effective level of peroxide in the plasma that has direct effect on microvessel endothelial cells is the net amount after the produced ROS in the vasculature were reacted with the plasma antioxidant enzymes. The measured plasma peroxide levels in human with hypertension are close to 10 μM ([@B106]) and in diabetic rats are about 10--15 μM ([@B218]). To better replicate the *in vivo* situations, the studies using individually perfused microvessels, conducted in the absence of blood cell components, directly perfused the vessel with a pathologically relevant net plasma H~2~O~2~ concentration and the changes in EC \[Ca^2+^\]~i~, microvessel permeability, and cell apoptosis status were assessed while the vessel was continuously exposed to a relatively constant concentration of ROS through the perfusion pipette with constantly refreshed perfusate ([@B234]). Comparing to the commonly used bolus application of high concentration of reactive reagents to the tissue or cell culture medium, the continuous perfusion of a pathologically relevant concentration of ROS in intact microvessels closely mimicked the *in vivo* situation. These detailed technical differences may explain some of the differences in results.

H~2~O~2~-Induced Excessively Produced NO and Microvessel Permeability {#S5.SS3}
---------------------------------------------------------------------

The distinct time courses of superoxide and H~2~O~2~-induced increases in microvessel permeability indicate that these two species of ROS may evoke cellular damage via different signaling mechanisms ([@B233], [@B234]). It is well recognized that low levels of NO participate in a wide range of physiological processes, whereas large amounts of NO lead to nitrosative stress and endothelial dysfunction. Increased production of ROS has been shown to cause increases in microvessel permeability, tissue damage, and organ dysfunction ([@B47]; [@B28]; [@B233]). A number of studies have suggested that NO regulates the interactions between oxidant-stimulated signaling pathways and endothelial barrier function and protects the cells from ROS-mediated deleterious effects ([@B35]; [@B98]; [@B102]; [@B214]; [@B147]). For instance, NO has been shown to attenuate oxidant-induced endothelial barrier dysfunction in cultured ECs ([@B126]; [@B70]), in isolated perfused organs ([@B90]; [@B155]), and in whole animal studies ([@B22]; [@B122]). However, there are also reports where NOS inhibitors do not modulate ROS-induced changes in endothelial barrier function or cell injury ([@B19]; [@B8]) or even NO can exacerbate H~2~O~2~-induced endothelial permeability in cultured ECs ([@B126]; [@B148]). It is thus apparent that the roles of endogenous vs. exogenous or basal vs. excessive NO in ROS-mediated endothelial barrier function remain equivocal and warrants more evidence to determine the conditions where NO may act either as a proinflammatory or protective mediator *in vivo*.

H~2~O~2~-induced increases in EC NO production have been indicated to play distinct roles in different vasculature ([@B26]). H~2~O~2~ is considered an important vasodilator in large arteries or arterioles through its activation on eNOS and increased NO production ([@B222]; [@B29]). Whereas in venules, the H~2~O~2~-induced excessive NO was linked to nitrosative stress and endothelial dysfunction ([@B226]; [@B13]; [@B237]; [@B76]; [@B231], [@B235]; [@B139]; [@B232]). H~2~O~2~-induced increases in EC NO and the relationship between NO and EC \[Ca^2+^\]~i~ were characterized in detail from studies conducted in intact microvessels and presented in [Figure 4](#F4){ref-type="fig"} ([@B234]). It was demonstrated that H~2~O~2~ at 10 μM, a concentration close to the plasma level in human disease conditions ([@B106]), induced an immediate and long lasting increased NO production, which was characterized by two phases. The initial phase with highest NO production rate occurred immediately upon H~2~O~2~ application, which was correlated with increased eNOS Ser^1177^ phosphorylation in the absence of elevated \[Ca^2+^\]~i~ and did not cause a corresponding increase in permeability. The second phase of increased NO occurred after 20 min of H~2~O~2~ perfusion when EC \[Ca^2+^\]~i~ started to increase, and was associated with Ca^2+^-dependent Thr^495^ dephosphorylation and blocked by LaCl~3~, a blocker for Ca^2+^ influx ([Figure 4](#F4){ref-type="fig"}; [@B234]). Comparing platelet activating factor (PAF)-induced NO production that occurred downstream from transient increases in EC \[Ca^2+^\]~i~ and was required for increases in microvessel permeability, the magnitude of H~2~O~2~-induced NO was about 6 times of PAF-induced NO ([Figure 5](#F5){ref-type="fig"}). Most importantly, H~2~O~2~-induced NO lasted 50 min, much longer than that of PAF-induced NO (6 min). This large amount of NO, instead of causing an immediate increase in microvessel permeability that occurred in PAF-stimulated microvessels ([@B237], [@B231]), lead to caspase activation, delayed and cumulative increases in EC \[Ca^2+^\]~i~, vascular cell apoptosis, and progressively increased microvessel permeability ([Figures 3](#F3){ref-type="fig"}, [6](#F6){ref-type="fig"}). The results also showed that the H~2~O~2~-induced caspase activation not only results in increases in EC \[Ca^2+^\]~i,~ but the increased \[Ca^2+^\]~i~ can further activate caspases. Blockade of Ca^2+^ influx by LaCl~3~ significantly attenuated H~2~O~2~-induced caspase activation. These observations suggested that H~2~O~2~-induced NO-mediated \[Ca^2+^\]~i~ overload and cell apoptosis can be augmented through a positive feedback mechanism. Importantly, inhibition of NOS prevented all of the H~2~O~2~-induced events including caspase activation, cell apoptosis, increases in endothelial \[Ca^2+^\]~i~ and microvessel permeability, indicating a crucial role of NO in H~2~O~2~-mediated vascular barrier dysfunction. However, the H~2~O~2~-induced largely increased NO (1st phase), in the absence of increased EC \[Ca^2+^\]~i~, did not increase microvessel permeability, suggesting excessive NO alone is not sufficient to increase microvessel permeability. By linking the timing of H~2~O~2~-induced increases in microvessel Lp ([Figure 3C](#F3){ref-type="fig"}) with the superimposed time courses of H~2~O~2~-induced changes in EC NO and \[Ca^2+^\]~i~ shown in [Figure 4B](#F4){ref-type="fig"}, the Lp increase only occurred after EC \[Ca^2+^\]~i~ was significantly elevated. Therefore, these studies evidently indicate that it is NO-mediated EC \[Ca^2+^\]~i~ overload that causes increases in permeability. The mechanisms involved in the excessive NO-mediated impairment of EC Ca^2+^ homeostasis are discussed in the flowing section with the focus on the interplay between ROS, NO, and reactive nitrogen species in vascular barrier dysfunction.

![Measurements of H~2~O~2~-induced EC NO in DAF-2 DA loaded rat mesenteric venules. **(A)** Perfusion of vessels with H~2~O~2~ (10 μmol/L) increases EC NO via an initial Ca^2+^ influx-independent (1st) phase followed by a 2nd Ca^2+^-dependent phase. The application of NOS inhibitors *N*^G^-monomethyl-[L]{.smallcaps}-arginine ([L]{.smallcaps}-NMMA) or AP-CAV prevent or reduce H~2~O~2~-induced NO in both phases, and blocking Ca^2+^ influx with LaCl~3~ only prevented the 2nd phase of NO production. **(B)** Superimposed time courses of NO production rate (df/dt, calculated from the cumulative DAF FI curve, left *Y*-axis) with the changes in EC \[Ca^2+^\]~i~ (right *Y*-axis) in H~2~O~2~-perfused vessels demonstrate that the H~2~O~2~-induced increases in EC \[Ca^2+^\]~i~ only started to increase during the 2nd phase of increased NO, but increased progressively thereafter. Used with permission ([@B234]).](fphys-11-00472-g004){#F4}

![Comparison of PAF and H~2~O~2~-induced NO production in rat mesenteric microvessels. NO was measured in DAF-2 DA loaded microvessels. When the vessel was exposed to PAF, the cumulative change of DAF-2 FI at plateau level was about 1.5 times of that of the control and lasted about 6 min (plateau indicates no further increased NO production). Whereas in H~2~O~2~ (10 μM) perfused microvessels, the maximum change of DAF-2 FI was about nine times of that of the control, about six times higher than that of PAF-induced NO production. Importantly, the increased NO lasted about 50 min. Modified and used with permission ([@B237]; [@B232]).](fphys-11-00472-g005){#F5}

![H~2~O~2~-induced vascular cell apoptosis. Representative confocal images of FLICA (indicator for activated caspase 3/7), Alexa488-Annexin-V (labeling externalized phosphatidylserine, PS), Calcein-AM (live cell staining), and merged images of Annexin-V with Calcein-AM in H~2~O~2~-perfused rat mesenteric venules. These images illustrate that H~2~O~2~ induces time and dose dependent caspase activation and vascular cell apoptosis. Importantly, pericytes start apoptosis earlier than endothelial cells (ECs) in the same vessel segment (i.e., with identical H~2~O~2~ concentration and exposure time), suggesting their higher vulnerability to ROS than ECs. Arrows indicate ECs and arrowheads indicate pericytes. \*ECs not stained with Calcein-AM. Used with permission ([@B234]).](fphys-11-00472-g006){#F6}

ROS, NO, ONOO^--^, and Microvessel Permeability {#S5.SS4}
-----------------------------------------------

Increased production of ONOO^--^ has been implicated to be associated with inflammation and various cardiovascular diseases ([@B57]; [@B94]; [@B216]). ONOO^--^, a highly reactive oxidant produced by the reaction of superoxide with NO, is capable of oxidizing lipid membranes, nucleic acids, and metabolic enzymes ([@B16]; [@B17]). A compelling body of evidence supports a role of ONOO^--^-mediated damage at inflammatory site ([@B167]). ONOO^--^ has been reported to cause disruption of endothelial cytoskeletal proteins ([@B94]; [@B142]) or activate upstream signaling cascades ([@B209]), leading to EC barrier dysfunction. In cultured ECs, ONOO^--^ has been shown to increase basal and agonist-stimulated Akt- and AMP-activated Ser^1179^ phosphorylation of eNOS, but decreased NO production and bioactivity ([@B240]). In addition, while ONOO^--^-induced accumulation of cGMP in ECs could regulate EC shape and function, activation of poly(ADP-ribose) synthetase (PARS) by ONOO^--^ is reported to suppress mitochondrial respiration and cause endothelial dysfunction ([@B191]). These findings suggest that ONOO^--^ can potentially alter endothelial function through complex mechanisms.

H~2~O~2~, in addition to inducing NO production, also increases superoxide production, which has been considered as important feed-forward mechanisms for ROS-mediated pathogenesis of cardiovascular diseases ([@B27]; [@B239]). *In vitro* studies reported that the H~2~O~2~-induced superoxide production was prevented by the inhibition of p22^phox^ with siRNA and knockout of gp91^phox^, the two transmembrane subunits of NAD(P)H oxidase, in cultured vascular endothelial cells ([@B114]; [@B50]). To further elucidate the underlying mechanism for H~2~O~2~-induced NO-dependent delayed increases in EC \[Ca^2+^\]~i~, cell apoptosis, and progressively increased microvessel permeability, additional studies were conducted in intact microvessels to explore the potential involvement of NO-derived other form of oxidant agent ([@B232]). Consistent with others report, the study first demonstrated increased production of superoxide in both ECs and pericytes in H~2~O~2~ perfused vessels, which was inhibited by DPI, a commonly used NAD(P)H oxidase inhibitor, supporting NAD(P)H oxidase as the primary source for the H~2~O~2~-induced superoxide production ([@B232]). This increased superoxide was not only concurrent but also in close proximity with H~2~O~2~-induced markedly increased NO, thus resulting in spontaneous generation of ONOO^--^. The direct evidence of H~2~O~2~-induced ONOO^--^ formation is demonstrated with an extensive NO-dependent tyrosine nitration in H~2~O~2~ perfusion microvessels ([Figure 7](#F7){ref-type="fig"}). Nitrotyrosine is a well-recognized biomarker for ONOO^--^, which commonly served as an indication of systemic nitroxidative stress ([@B159]; [@B232]). The direct effects of ONOO^--^ in intact microvessels and its role in H~2~O~2~-induced permeability increase were further characterized in a recent study conducted in intact microvessels. The study showed that the NO-derived ONOO^--^ plays an important role in H~2~O~2~-induced increases in microvessel permeability and the application of an endogenous ONOO^--^ scavenger, uric acid, prevents H~2~O~2~-induced increases in endothelial \[Ca^2+^\]~i~ and microvessel permeability. The application of exogenous ONOO^--^ in microvessels also showed delayed dose- and time-dependent increases in EC \[Ca^2+^\]~i~ and permeability, a pattern similar to that induced by H~2~O~2~ ([Figure 8](#F8){ref-type="fig"}). Most importantly, exogenous ONOO^--^ activates eNOS and further increases NO production, resulting in amplified ONOO^--^ formation and severe tissue damage. These findings suggest that H~2~O~2~-induced excessive NO-derived ONOO^--^ is the primary mediator of H~2~O~2~-induced cell injury and progressively increased microvascular permeability. The fact that ONOO^--^ could cause further activation of eNOS with amplified NO constitutes a self-promoted augmentation of nitroxidative stress, which results in progressively increased permeability. The signaling cascade and the sequential events found in H~2~O~2~-perfused intact microvessel are illustrated in [Figure 9](#F9){ref-type="fig"} ([@B232]), which provide mechanistic insights into a better understanding of the pathogenesis of oxidant-induced RNS-mediated microvascular dysfunction.

![H~2~O~2~ induced NO-dependent tyrosine nitration in rat mesenteric venules. Confocal images showing the fluorescent immunostaining of nitrotyrosine in vessels perfused with control (Ringer solution containing 1% BSA, left), H~2~O~2~ (10 μmol/L, middle, arrows indicate the nucleus of ECs without nitrated tyrosine formation), and H~2~O~2~ in the presence of L-NMMA (2 mmol/L, right). Used with permission ([@B232]).](fphys-11-00472-g007){#F7}

![ONOO^--^ induced NO production and increases in EC \[Ca^2+^\]~i~ in perfused rat mesenteric venules. Perfusion of vessels with ONOO^--^ (50 μM) increased NO in 2 phases followed by increases in EC \[Ca^2+^\]~i~. The NO production rate (df/dt, left *Y* axis) derived from cumulative DAF-2 FI in ONOO^--^-perfused vessels is superimposed with the time course of increased EC \[Ca^2+^\]~i~ (right *Y* axis). The application of LaCl~3~ (50 μM) did not affect ONOO^--^-induced initial NO production but prevented the 2nd phase of NO production, indicating the 2nd phase of NO is Ca^2+^influx-dependent. Importantly, EC \[Ca^2+^\]~i~ only started to increase after 20 min of ONOO^--^ perfusion, but increased progressively thereafter, a pattern similar to that observed in H~2~O~2~-perfused vessels. Used with permission ([@B232]).](fphys-11-00472-g008){#F8}

![Schematic diagram illustrating the mechanisms of H~2~O~2~-induced microvessel barrier dysfunction. H~2~O~2~ at pathophysiological levels activate eNOS and NADPH oxidase in the endothelium and pericytes, leading to increased formation of NO and O~2~^--^. The temporal and spatial proximity of largely produced NO and O2^--^ promote the formation of ONOO^--^, a more potent oxidant, leading to ONOO^--^-mediated lipid peroxidation, protein tyrosine nitration, subsequent impairment of intracellular Ca^2+^ homeostasis, and vascular cell apoptosis. Both NO-derived ONOO^--^ and the delayed increases in EC \[Ca^2+^\]~i~ are able to further activate eNOS, resulting in amplified NO production and NO-dependent downstream cascade. These positive feedback loops, indicated by red dotted lines, play an important role in sustained production of ONOO^--^, and eventually ONOO^--^-mediated endothelial cell Ca^2+^ overload, vascular cell apoptosis, and progressively increased microvessel permeability. The application of inhibitors (shaded boxes) blocks the downstream events. DPI (diphenylene iodonium, NADPH oxidase inhibitor); eNOS: endothelial nitric oxide synthase; CAV-1: Caveolin-1 (eNOS inhibitor); z-VAD-FMK: caspase inhibitor. Used with permission ([@B232]).](fphys-11-00472-g009){#F9}

Role of Basal No in Microvessel Barrier Function {#S6}
================================================

Basal NO and agonist-induced excessive NO have been shown to play different roles in the regulation of microvessel permeability ([@B237]; [@B231]; [@B220]). As discussed above, ROS- or inflammatory mediator-induced excessive NO contributes to increased vascular permeability through different mechanisms ([@B135]; [@B226]; [@B120]; [@B217]; [@B78]; [@B237]; [@B76]; [@B168]; [@B235]), whereas basal NO was reported to play a critical role in preventing leukocyte adhesion ([@B64]; [@B101]; [@B135]) and the adhesion and aggregation of platelets ([@B161], [@B162]). Reduced basal NO synthesis or NO bioavailability has been reported in various disease conditions including hypertension, diabetes, hypercholesterolemia, and reperfusion injury, which was commonly linked to endothelial dysfunction and vascular inflammation ([@B134]; [@B156]). Genetic deletion of eNOS or over expression of caveolin-1, an endogenous inhibitor of eNOS, has been shown to cause increased leukocyte adhesion and macrophage infiltration, and accelerated atherosclerosis in apolipoprotein E (apoE) deficient mice ([@B169]; [@B59]; [@B7]; [@B63]; [@B154]). Those studies indicated an important role of basal NO in maintaining vascular function and preventing vascular inflammation, but the mechanisms were not well defined. Although the animals with genetic deletion of eNOS generated a constant reduction of NO systemically, such condition may trigger complex adaptation and compensatory effects in the vascular system. Therefore, the inflammatory manifestation observed in those animals may not unequivocally represent the role of basal NO.

Some *in vivo* studies demonstrated that the application of NOS inhibitor through either systemic injection or superfusion to the vascular beds induced increases in microvessel permeability ([@B97]; [@B103]). However, reduced basal NO in the presence of blood would cause leukocyte and platelet adhesion, which may confound the direct effect of basal NO on permeability. When studies were conducted in individually perfused vessels in the absence of blood components in the vessel lumen, reduced basal NO production by NOS inhibitor or caveolin-1 peptide, AP-CAV, showed no effect on basal microvessel permeability ([@B220]). The increased permeability observed in whole vascular bed studies could be attributed to the reduced basal NO-induced increases in adherent leukocytes. In the presence of any inflammatory stimulus, the adherent leukocytes could be activated to release ROS and thus increase the permeability. The mechanisms of reduced basal NO-induced leukocyte adhesion were demonstrated recently ([@B220]; [@B66]). Those studies showed that when blood flow was resumed in vessels that were pretreated with NOS inhibitor or AP-CAV to reduce endothelial basal NO, large amounts of leukocytes quickly adhered to rat venules and the adhesion was demonstrated to be EC ICAM-1 mediated ([Figure 10](#F10){ref-type="fig"}; [@B220]). Most importantly, the ICAM-1-mediated adhesion occurred very quickly (less than 30 min), which rules out the possibility of *de novo* protein synthesis and translocation. Such rapid changes in ICAM-1 adhesiveness predicts a NO-dependent regulation of the adhesive binding avidity of constitutively expressed endothelial ICAM-1. This prediction was further validated by an additional *in vitro* cell culture study showing that the reduced basal NO-induced increases in EC adhesive binding were mediated by Src-dependent ICAM-1 activation through its phosphorylated state ([@B66]).

![Perfusion of rat mesenteric venules with AP-CAV, an endogenous NOS inhibitor, induced basal NO-dependent ICAM-1 mediated leukocyte adhesion. Intact venules were perfused by AP-CAV for 30 min followed by resuming blood flow in the same vessel for 10 min. Leukocyte adhesion was quantified when each vessel was recannulated with BSA-Ringer solution. **(A)** Video images of a perfused venule under control conditions and after AP-CAV (10 μM)-induced leukocyte adhesion, and the administration of a NO donor, sodium nitroprusside (SNP), abolished AP-CAV-induced leukocyte adhesion. **(B)** AP-CAV induced dose-dependent increases in the binding affinity between EC ICAM-1 and its blocking antibody mAb1A29. Confocal images of mAb1A29 (green) and vascular cell nuclei (red) immunofluorescence co-staining under control conditions, after AP-CAV perfusion, and after adding SNP to AP-CAV perfused vessels. **(C)** Perfusion of vessels with ICAM-1 inhibitory antibody, mAb1A29, significantly attenuated AP-CAV induced leukocyte adhesion. \* and † indicate a significant increase and decrease from the control, respectively. Used with permission ([@B220]).](fphys-11-00472-g010){#F10}

Other *in vitro* studies proposed that the inhibition of eNOS-derived NO does not directly contribute to EC conversion to a pro-adhesive phenotype but rather interferes with the generation of ROS by NADPH oxidase and results ROS-mediated inflammatory response ([@B145]; [@B104]). In contrast to this proposal, the timing and pattern of leukocyte adhesion observed in intact microvessels ([@B220]) strongly support a direct association between basal NO and adhesive states of ECs. Importantly, if the increased adhesiveness of ECs is ROS mediated, an increased permeability should be observed. Instead, the results showed that basal NO reduction-induced adherent leukocytes do not cause permeability increase unless additional stimuli (such as fMLP) are applied to trigger neutrophil respiratory burst ([@B220]). Taken together, these studies demonstrated that basal NO is essential for maintaining the non-adhesive state of endothelium through regulation of the adhesive binding of endothelial ICAM-1.

Role of ROS in Pericyte Loss and Microvessel Permeability {#S7}
=========================================================

The albuminal side of endothelium is surrounded by a morphologically distinct cell termed pericyte. Pericyte was first described as perivascular contractile cell that wrap around the ECs of microvessels ([@B181]). They are also known as Rouget cells named after their discoverer, or referred to as mural cells because of their perivascular position, or as microvascular smooth muscle cells (SMCs) because of their contractile nature ([@B5]; [@B184]; [@B206]; [@B58]).

Pericyte Structure and Function in Microvessels {#S7.SS1}
-----------------------------------------------

Pericytes are found on pre-capillary arterioles, capillaries, post-capillary venules, and collecting venules of many organs, but they are more extensive in postcapillary values ([@B181]; [@B176]). They are embedded within the endothelial basement membrane (BM) and have a cell body with a prominent nucleus, a small amount of cytoplasm with extending long processes along the longitudinal axis of the blood vessels, and usually span many ECs ([@B5]). The morphology of pericyte is also reported to be very distinct in different organs ranging from a typical flattened or elongated, stellate-shaped cell with multiple cytoplasmic processes encircling a large albuminal vessel area in central nervous system (CNS) to that of a mesangial cell of kidney glomerulus as rounded, compact, and covering a minimal albuminal vessel area ([@B4]; [@B75]). The pericyte coverage of the endothelial albuminal surface varies at different organs and vascular beds, and it reflects the relative ratio between the ECs to pericytes ([@B181]). The highest pericyte coverage of microvessels is reported in CNS and retina with EC-to-pericyte ratio of 1:1 to 3:1 forming blood-brain barrier and blood-retinal barrier, and the lower EC-to-pericyte ratio of 100:1 in skeletal muscle ([@B181]; [@B176]). Pericytes and ECs not only share a common BM, they are directly connected to each other through the interruptions in the BM ([@B165]). The intimate relationship between albuminal pericytes and luminal ECs through the BM is not only the physical communications; it involves several signaling mechanisms that regulate pericyte-EC interactions and communication. The signaling pathways have been extensively reviewed by several authors ([@B4]; [@B211]; [@B65]; [@B5]; [@B82]; [@B212]). Investigations with genetic mouse models have showed that pericytes and ECs are interdependent, as a result a primary defect in one cell type have inevitable consequences on the other cell ([@B4]; [@B65]). Because of its intimate relationship with endothelium and BM, pericytes have recently come into focus as an emerging key factor in the regulation of diverse vascular functions both in health and disease. Briefly, pericytes are functionally associated with the regulation of vascular contraction and blood flow ([@B176]; [@B165]; [@B18]; [@B206]), vessel permeability ([@B54]; [@B225]), vascular stability ([@B211]), BM organization ([@B186]), and angiogenesis ([@B67]; [@B18]).

Role of Pericytes in the Regulation of Microvessel Permeability {#S7.SS2}
---------------------------------------------------------------

Vascular endothelial cells have been recognized as the principal barrier for fluid and solute exchange between circulating blood and surrounding tissues. During inflammation, the increased permeability mainly occurs at venules. The majority of the venular wall is wrapped by perivascular cells, mainly pericytes ([@B140]). The prime location of pericytes suggests that they may serve as an additional barrier at the vessel walls that restricts macromolecule leakage when permeability is increased. Additionally, based on its contractile nature, it may also actively involve the regulation of microvascular permeability. The role of pericytes in microvessel barrier function has been controversial. Some of the studies reported that the contraction of pericytes prompted the gap formation between endothelial cells ([@B91]). While other *in vivo* studies indicated that pericytes might protect endothelial junctions upon histamine exposure ([@B182]). In a microvascular lung pericyte/EC co-culture study, addition of pericytes is reported to increase the permeability barrier compared to EC alone ([@B49]). A study using a pericyte deficient mouse model revealed that the lack of pericytes increased the permeability of BBB to water and a range of solute tracers ([@B6]; [@B43]). Another *in vivo* evidence derived from inflamed vessels demonstrated that pericyte F-actin bundles and pericyte processes completely covered largely separated VE-cadherin and open endothelial gaps at the peak of the permeability increases ([@B225]). [Figure 11](#F11){ref-type="fig"} illustrated details with confocal images and ultrastructural micrograph. These *in vivo* observations suggest that pericytes, instead of promoting endothelial gap formation, play an important role in lessening a potentially higher degree of leakage when endothelial barrier is impaired. In vessels going through inflammation-induced vascular remodeling, the EM structure of the vascular walls showed proliferated perivascular cells and expanded extracellular matrix, which not only serve as a secondary barrier that lessen the vascular leakage but also provide a supporting structure to stabilize the microvessel wall during stimulation-induced EC cytoskeleton contractions ([@B225]).

![Confocal and electron micrographs of rat mesenteric venules demonstrating the positioning of pericyte processes in relation to open endothelial junctions at PAF-induced peak increase of Lp. **(A)** Confocal images: Image a is a partial projection of the lower half of the vessel wall with dual staining of F-actin (red) and VE-cadherin (green). An arrow indicates a typical pericyte structure: a single nucleus with multiple cellular processes. Details of a local region of the vessel wall (rectangular box) are displayed in images b to e with a higher magnification. Image b is a dual channel image projection of both endothelial and pericyte layers demonstrating that all of the open VE-cadherin is covered by aggregated pericyte actin bundles. Image c shows large separations of endothelial VE-cadherin. Image d is a dual channel image projection at the endothelial cell layer showing the changes in endothelial F-actin and VE-cadherin. Image e shows the aggregated pericyte F-actin bundles (a projection of image sections blow endothelial cells). Micrograph **(B)** shows the structural changes in vascular wall at the PAF-induced Lp peak. It displays a wide open endothelial gap with intact basement membrane. Consistent with confocal images, two extended overlapping pericyte processes provide a complete coverage of the endothelial gap. These images suggest a role of pericytes in stabilizing the vascular wall and lessening an otherwise greater magnitude of leakage while endothelial barrier is impaired. Modified and used with permission ([@B225]).](fphys-11-00472-g011){#F11}

ROS-Mediated Pericyte Apoptosis {#S7.SS3}
-------------------------------

As pericytes are abundant in microvasculature and have been linked to a wide array of vascular functions, alterations in pericyte coverage or pericyte dysfunctions can contribute to multiple vascular pathologies. Accordingly, pericyte loss has been demonstrated in the pathogenesis of several microvascular complications under disease conditions ([@B4]; [@B82]; [@B206]; [@B212]; [@B58]). The most characterized and established microvascular complications with pericyte loss are associated with diabetes, such as diabetic retinopathy, diabetic nephropathy, and diabetic neuropathy ([@B206]; [@B212]; [@B58]). [Figure 12](#F12){ref-type="fig"} illustrates the progression of retina vessels from hyperglycemia and oxidative stress-induced loss of pericytes and endothelial cells, increased vascular permeability, to the development of proliferative retinopathy ([@B58]). Loss of pericyte number and coverage has also been reported in neurodegeneration and Alzheimer's disease ([@B166]; [@B173]). Ischemic stroke within CNS is reported to cause microvascular pericyte loss during ischemia/reperfusion ([@B82]). However, the mechanisms involved in pericyte loss under those pathological conditions remain unclear. In all of the diseases mentioned above, oxidative stress plays an important role and ROS-induced cell injury could be the main cause leading to cell apoptosis. An early indicator of apoptosis is the translocation of phosphatidylserine (PS) from the inner to the outer leaflet of the plasma membrane, which can be detected by Annexin V, a phospholipid-binding protein that has high affinity for PS. As that shown in [Figures 3](#F3){ref-type="fig"}, [6](#F6){ref-type="fig"}, perfusion of microvessels with H~2~O~2~ at 10 μM for 2 h caused caspase activation, cell apoptosis, followed by EC Ca^2+^ overload and increased microvessel permeability ([@B234]). Importantly, when the apoptotic cells in H~2~O~2~-perfused vessels were illustrated by Annxin-V staining ([Figure 6](#F6){ref-type="fig"}), pericytes undergo apoptosis earlier than most of the ECs, albeit both of them were exposed to the same concentration of H~2~O~2~ with identical exposure time. This observation indicates that pericyte are more vulnerable to oxidative stress than ECs. This may also explain the early loss of microvascular pericytes that was commonly found in diabetic patients and animals as that shown in [Figure 12](#F12){ref-type="fig"}. The loss of pericytes in retina microvessels could be the main cause for aneurism formation in diabetic retinopathy and the increased plasma levels of ROS could play an important role ([@B178]).

![Retina vascular progression to proliferative retinopathy under diabetic conditions. Hyperglycemia and oxidative stress cause pericyte apoptosis and increases in microvessel permeability. The loss of pericytes and endothelial cells will further increase fluid and protein leakage in the retina and immune cell infiltration. These intra-ocular vascular changes will then contribute to the development of proliferative retinopathy. Modified and used with permission ([@B58]).](fphys-11-00472-g012){#F12}

In summary, in recent years our knowledge in pericyte characterization, functions, and its involvement in pathological conditions has evolved significantly, but there are far more questions than answers. The multifaceted role of pericytes thus emphasizes the need of further studies in intact microvasculature with novel *in vivo* and *ex vivo* experimental approaches to fully understand the specific pericyte function in health and disease, and to further explore their regenerative potential and the signaling pathways affected vascular function in different pathological states.

Oxidative Stress and Antioxidant Counter Balance {#S8}
================================================

It is now well recognized that the state of oxidative stress in the vascular wall is developed following an imbalance between ROS and antioxidant enzymes where excess cellular production of ROS outperforms the capacity of endogenous antioxidant defense mechanisms. Growing evidence from basic and clinical studies suggest that increased oxidative stress plays a pivotal role in the initiation and progression of many cardiovascular diseases ([@B119]; [@B108]; [@B61]; [@B24]). While animal studies supported the potential role of antioxidants in preventing oxidative stress-induced vascular disorders ([@B132]; [@B20]; [@B111]), clinical trials with various antioxidants have been disappointing and failed to demonstrate conclusive results ([@B119]; [@B108]; [@B61]; [@B24]). While several factors have been identified for the lack of clinical efficacy of antioxidants ([@B119]; [@B61]; [@B24]), it has become essential to have a better understanding of ROS-mediated signaling mechanisms, their localization, and the integration of both ROS-dependent transcriptional and signaling pathways in vascular pathophysiology ([@B119]). Consequently, the field of oxidative stress has recently been widened significantly and it is often viewed as an imbalance of genes encoding antioxidant enzymes and proteins, and how those genes are regulated under disease conditions with increased ROS production.

Antioxidant enzymes such as SOD, catalase, and glutathione peroxidase are able to break down ROS promptly to other less reactive and non-reactive downstream products. These proteins play key roles in counter balance of oxidative stress-induced cell damage. The regulation of cellular redox homeostasis mainly occurs at the transcription level. Cells activate transcription of protective antioxidant genes under oxidative stress via varieties of redox-sensitive transcription factors, of which Nrf2 has been recognized as a master regulator of antioxidative responses ([@B137]; [@B2]). Under normal physiological conditions, Nrf2 is located in the cytosol at a low concentration and is the target for proteasomal degradation by its interaction with a cytosolic regulatory protein Kelch-like ECH-associated protein (Keap1) ([@B143]). With increased ROS, Nrf2 dissociates from Keap1 and translocates to the nucleus where it binds to the promoters of genes containing the *cis*-acting antioxidant response element (ARE). Its binding to ARE at nucleus promotes the transcription of a wide variety of antioxidant genes ([@B118]). Many ARE genes are involved in detoxification enzymes such as glutathione-S-transferases, heme oxygenase-1, and NAD(P)H dehydrogenase ([@B143]) and hence the Nrf2 activity has been viewed as a key indicator of cellular antioxidant capacity. Since many factors may affect Nrf2 activity such as its dissociation from Keap1, translocation to nucleus, its efficiency in binding to ARE due to enhanced nuclear export and degradation, exactly how Nrf2 activity is regulated under different pathological condition-induced oxidative stress remains to be uncovered. The Nrf2/Keap1-ARE signaling pathways and biochemical aspect of their interactions under different disease conditions have been reviewed elsewhere ([@B34]; [@B2]).

Nrf2 dysfunction or reduced Nrf2 activity has been found in certain oxidative stress-associated conditions such as aging-related vascular inflammation ([@B202]; [@B201]), obesity-induced neurovascular dysfunction ([@B194]), and the disturbed flow-mediated atheroprone regions of the vasculature ([@B127]). Genetic deletions of Nrf2 in mice and rats are viable under normal conditions, but they have shown higher sensitivity to increased oxidant stress-induced vascular damages and organ dysfunction ([@B31]; [@B32]; [@B33]; [@B200]; [@B158]). High fat diet-induced increases in vascular ROS levels were greater in Nrf2^--/--^ than in Nrf2^+/+^ mice ([@B200]). Nrf2 deficient rats lead to the development of salt-induced oxidative stress, endothelial dysfunction, and microvessel rarefaction in normotensive rats ([@B158]). A recent study conducted in individually perfused microvessels showed that Nrf2 deficient rats have higher plasma H~2~O~2~ levels than WT rats under both normal and STZ-induced diabetic conditions. Compared to WT rats, microvessels in Nrf2 deficient rats showed significantly higher basal permeability (measured by hydraulic conductivity, Lp) as well as increased permeability responses to PAF in both normal and STZ-induced diabetic rats ([@B218]). Importantly, the magnitude of the Lp increases mirrored the plasma H~2~O~2~ levels where higher ROS levels correlated with higher permeability increases when exposed to an inflammatory mediator, PAF. These studies indicate an important antioxidant role of Nrf2 under both normal and pathological conditions.

The important role of Nrf2 in the regulation of antioxidant responses led many studies to search pharmacological activators or inducers of Nrf2 to enhance Nrf2-driven antioxidant defense ([@B177]; [@B34]; [@B174]). The induction of NRF2-driven antioxidant response in whole animal showed reduced ischemic damage from stroke and mitochondrial stress ([@B177]), and increased expression of Nrf2-driven genes protected the blood brain barrier after brain injury ([@B230]). To date, increasing number of chemical compounds and plant natural compounds have been recognized to have antioxidant effect mediated by Nrf2-ARE related pathways from *in vivo* and *in vitro* studies ([@B34]). Some of the Nrf2 inducer supplements also showed promising anti-aging and anti-oxidant effects in clinical studies ([@B68]; [@B152]). However, the conclusive evidence of their ability in improving clinical outcomes has been limited and warrants further investigation.

Current studies indicate that increased ROS and/or reduced antioxidant defense play important roles in priming endothelial cells and transitioning them into a phenotype with higher susceptibility to additional inflammatory stimuli or pathological conditions. Importantly, these studies open up a novel area of future investigations where direct upregulation of Nrf2 antioxidant defense system could prove to be a highly valuable therapeutic strategy against conditions associated with increased oxidative stress.

Summary {#S9}
=======

Clinical and experimental evidence indicate that increased vascular permeability contributes to many disease-associated vascular complications. It is thus important to identify the critical factors and underlying mechanisms involved in permeability increases. Increased production of ROS has been implicated in the pathogenesis of many cardiovascular diseases. As those outlined in this review, each species of ROS plays different roles in the regulation of vascular function. Importantly, one species of ROS can further amplify redox signaling, resulting in augmented oxidative and nitroxidative stress. Increasing number of studies recognize that H~2~O~2~, a relatively stable reactive oxygen metabolite, plays an important role in ROS-mediated vascular barrier dysfunction. For decades, increased ROS-induced vascular dysfunction has often been associated with reduced NO production through eNOS uncoupling. However, emerging evidence revealed that the H~2~O~2~-induced EC \[Ca^2+^\]~i~ overload, cell apoptosis, and progressively increased microvessel permeability were mediated by H~2~O~2~-induced excessive NO and NO-derived peroxynitrite. The interplay of ROS, NO, and RNS followed by a self-promoted amplification of nitroxidative stress contributes to ROS-mediated microvascular dysfunction, including early stage of pericyte loss in microvessels. The schematic diagram shown in [Figure 13](#F13){ref-type="fig"} summarizes the underlying mechanisms involved in leukocyte-dependent and ROS-mediated microvessel barrier dysfunction. Future studies on molecular mechanisms and gene regulations of ROS overproduction, targeted interference of the amplification cascade, or enhancement of the antioxidant would benefit the development of therapeutic strategies to alleviate ROS-mediated vascular barrier dysfunction, which underlies a variety of cardiovascular diseases.

![Schematic diagram summarizing the underlying mechanisms involved in leukocyte-dependent and ROS-mediated microvessel barrier dysfunction.](fphys-11-00472-g013){#F13}
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